Onco3R Therapeutics
Pre-clinicalOnco3R Therapeutics is a clinical-stage biotech company developing next-generation precision medicines for oncology and immunology. Our pipeline focuses on novel targets including SIK3, FGFR3, SMARCA2, and P53.
Founded
2020
Focus
AntibodiesBiologics
About
Onco3R Therapeutics is a clinical-stage biotech company developing next-generation precision medicines for oncology and immunology. Our pipeline focuses on novel targets including SIK3, FGFR3, SMARCA2, and P53.
Funding History
2Total raised: $17.5M
Series A$15MUndisclosedJun 15, 2022
Seed$2.5MUndisclosedJun 15, 2020
Company Info
TypePrivate
Founded2020
LocationLeuven, Belgium
StagePre-clinical
Contact
SIMILAR COMPANIES
Miracor Medical
Pre-clinical · Zaventem
AML Clinical Services
Pre-clinical · Leuven
Anacura
Pre-clinical · Ghent
Aseptic Technologies
Pre-clinical · Gembloux
Aspect Analytics
Pre-clinical · Leuven
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile